Spark Investment Management LLC continued to hold its stake in shares of Wright Medical Group N.V. (NASDAQ:WMGI) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 41,800 shares of the medical device company’s stock at the end of the second quarter. Spark Investment Management LLC’s holdings in Wright Medical Group N.V. were worth $1,149,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently made changes to their positions in the stock. Mcrae Capital Management Inc. increased its stake in shares of Wright Medical Group N.V. by 2.7% in the first quarter. Mcrae Capital Management Inc. now owns 9,457 shares of the medical device company’s stock valued at $294,000 after buying an additional 250 shares during the period. Commerce Bank increased its stake in shares of Wright Medical Group N.V. by 7.4% in the first quarter. Commerce Bank now owns 18,837 shares of the medical device company’s stock valued at $586,000 after buying an additional 1,300 shares during the period. Swiss National Bank increased its stake in shares of Wright Medical Group N.V. by 0.9% in the first quarter. Swiss National Bank now owns 153,794 shares of the medical device company’s stock valued at $4,786,000 after buying an additional 1,400 shares during the period. Legal & General Group Plc increased its stake in shares of Wright Medical Group N.V. by 4.1% in the first quarter. Legal & General Group Plc now owns 36,155 shares of the medical device company’s stock valued at $1,125,000 after buying an additional 1,424 shares during the period. Finally, US Bancorp DE increased its stake in shares of Wright Medical Group N.V. by 41.3% in the second quarter. US Bancorp DE now owns 5,624 shares of the medical device company’s stock valued at $155,000 after buying an additional 1,644 shares during the period.

Wright Medical Group N.V. (WMGI) opened at 28.05 on Thursday. Wright Medical Group N.V. has a 1-year low of $20.50 and a 1-year high of $31.53. The stock has a 50 day moving average of $27.21 and a 200-day moving average of $27.93. The firm’s market capitalization is $2.93 billion.

Wright Medical Group N.V. (NASDAQ:WMGI) last issued its quarterly earnings results on Wednesday, August 2nd. The medical device company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.02. Wright Medical Group N.V. had a negative net margin of 36.04% and a negative return on equity of 6.22%. The firm had revenue of $179.69 million for the quarter, compared to analyst estimates of $178.17 million. During the same period in the previous year, the business earned ($0.11) EPS. The company’s revenue was up 5.3% compared to the same quarter last year. On average, equities research analysts anticipate that Wright Medical Group N.V. will post ($0.29) earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: “Spark Investment Management LLC Has $1,149,000 Position in Wright Medical Group N.V. (NASDAQ:WMGI)” was reported by Watch List News and is the property of of Watch List News. If you are accessing this story on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The legal version of this story can be accessed at https://www.watchlistnews.com/spark-investment-management-llc-has-1149000-position-in-wright-medical-group-n-v-nasdaqwmgi/1468052.html.

Several analysts have issued reports on the stock. BMO Capital Markets reissued a “buy” rating and set a $34.00 target price on shares of Wright Medical Group N.V. in a research note on Thursday, May 4th. ValuEngine raised shares of Wright Medical Group N.V. from a “sell” rating to a “hold” rating in a research note on Friday, June 2nd. Needham & Company LLC reissued a “hold” rating on shares of Wright Medical Group N.V. in a research note on Thursday, May 4th. Oppenheimer Holdings, Inc. set a $29.00 target price on shares of Wright Medical Group N.V. and gave the company a “hold” rating in a research note on Thursday, May 4th. Finally, Jefferies Group LLC reaffirmed a “buy” rating and issued a $33.00 price target on shares of Wright Medical Group N.V. in a research note on Friday, August 4th. One research analyst has rated the stock with a sell rating, six have given a hold rating and seven have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $32.25.

In other Wright Medical Group N.V. news, SVP Jennifer S. Walker sold 10,000 shares of Wright Medical Group N.V. stock in a transaction on Friday, June 9th. The shares were sold at an average price of $26.77, for a total value of $267,700.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Julie Andrews sold 1,480 shares of Wright Medical Group N.V. stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $27.11, for a total transaction of $40,122.80. The disclosure for this sale can be found here. Insiders sold a total of 40,655 shares of company stock worth $1,116,708 over the last quarter. Company insiders own 3.50% of the company’s stock.

About Wright Medical Group N.V.

Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.

Want to see what other hedge funds are holding WMGI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Wright Medical Group N.V. (NASDAQ:WMGI).

Institutional Ownership by Quarter for Wright Medical Group N.V. (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.